6533b81ffe1ef96bd1276fa6
RESEARCH PRODUCT
Additional file 4: Figure S2. of Serum metabolites in non-alcoholic fatty-liver disease development or reversion; a targeted metabolomic approach within the PREDIMED trial
Christopher PapandreouMònica BullòFrancisco TinahonesMiguel Martínez-gonzálezDolores CorellaGeorgios FragkiadakisJosé López-mirandaRamon EstruchMontserrat FitóJordi Salas-salvadósubject
description
Principal component analysis (PCA) model to discriminate between the baseline and final states in group 1 (participants not meeting the NAFLD criteria at baseline and at the end of follow-up). Model diagnostics (A = 6, R2X = 0.621, Q2X = 0.160) (DOCX 43 kb)
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2017-01-01 |